134 related articles for article (PubMed ID: 15784749)
1. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.
Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; Cobelli C; Trajanoski Z
Bioinformatics; 2005 May; 21(10):2200-9. PubMed ID: 15784749
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mass spectral serum profiles for biomarker selection.
Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
[TBL] [Abstract][Full Text] [Related]
3. Independent component analysis-based penalized discriminant method for tumor classification using gene expression data.
Huang DS; Zheng CH
Bioinformatics; 2006 Aug; 22(15):1855-62. PubMed ID: 16709589
[TBL] [Abstract][Full Text] [Related]
4. Feature extraction and dimensionality reduction for mass spectrometry data.
Liu Y
Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
[TBL] [Abstract][Full Text] [Related]
5. Sample classification from protein mass spectrometry, by 'peak probability contrasts'.
Tibshirani R; Hastie T; Narasimhan B; Soltys S; Shi G; Koong A; Le QT
Bioinformatics; 2004 Nov; 20(17):3034-44. PubMed ID: 15226172
[TBL] [Abstract][Full Text] [Related]
6. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
7. Structured polychotomous machine diagnosis of multiple cancer types using gene expression.
Koo JY; Sohn I; Kim S; Lee JW
Bioinformatics; 2006 Apr; 22(8):950-8. PubMed ID: 16452113
[TBL] [Abstract][Full Text] [Related]
8. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
[TBL] [Abstract][Full Text] [Related]
11. Gene selection in cancer classification using sparse logistic regression with Bayesian regularization.
Cawley GC; Talbot NL
Bioinformatics; 2006 Oct; 22(19):2348-55. PubMed ID: 16844704
[TBL] [Abstract][Full Text] [Related]
12. Detecting common gene expression patterns in multiple cancer outcome entities.
Yang X; Bentink S; Spang R
Biomed Microdevices; 2005 Sep; 7(3):247-51. PubMed ID: 16133813
[TBL] [Abstract][Full Text] [Related]
13. Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory.
Takahashi H; Aoyagi K; Nakanishi Y; Sasaki H; Yoshida T; Honda H
J Biosci Bioeng; 2006 Jul; 102(1):46-52. PubMed ID: 16952836
[TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.
Petricoin EF; Liotta LA
Curr Opin Biotechnol; 2004 Feb; 15(1):24-30. PubMed ID: 15102462
[TBL] [Abstract][Full Text] [Related]
15. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
16. A combination of rough-based feature selection and RBF neural network for classification using gene expression data.
Chiang JH; Ho SH
IEEE Trans Nanobioscience; 2008 Mar; 7(1):91-9. PubMed ID: 18334459
[TBL] [Abstract][Full Text] [Related]
17. Recursive gene selection based on maximum margin criterion: a comparison with SVM-RFE.
Niijima S; Kuhara S
BMC Bioinformatics; 2006 Dec; 7():543. PubMed ID: 17187691
[TBL] [Abstract][Full Text] [Related]
18. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
19. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
20. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
